Fibrin-targeting delivery: a novel platform for cardiac regenerative medicine.

about

Targeted delivery of thymosin beta 4 to the injured myocardium using CREKA-conjugated nanoparticles.Circular RNAs as Therapeutic Agents and Targets

P2860

Q42044067-661D0AD4-D4F3-4472-8000-C7B5ECC25949 Q57817032-959FE6A8-AD0C-43E7-8DDE-2FE6247CD230

P2860

Fibrin-targeting delivery: a novel platform for cardiac regenerative medicine.

Item

http://www.wikidata.org/entity/Q42359748

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Fibrin-targeting delivery: a novel platform for cardiac regenerative medicine.

@en

Fibrin-targeting delivery: a novel platform for cardiac regenerative medicine.

@nl

type

Item

label

Fibrin-targeting delivery: a novel platform for cardiac regenerative medicine.

@en

Fibrin-targeting delivery: a novel platform for cardiac regenerative medicine.

@nl

prefLabel

Fibrin-targeting delivery: a novel platform for cardiac regenerative medicine.

@en

Fibrin-targeting delivery: a novel platform for cardiac regenerative medicine.

@nl

P1476

Fibrin-targeting delivery: a novel platform for cardiac regenerative medicine.

@en

P2093

Junbo Ge

http://www.w3.org/2001/XMLSchema#string

Juying Qian

http://www.w3.org/2001/XMLSchema#string

Minghui Li

http://www.w3.org/2001/XMLSchema#string

Yanan Song

http://www.w3.org/2001/XMLSchema#string

Yerkintay Guliya

http://www.w3.org/2001/XMLSchema#string

Yunli Shen

http://www.w3.org/2001/XMLSchema#string

Zheyong Huang

http://www.w3.org/2001/XMLSchema#string

Zhiqing Pang

http://www.w3.org/2001/XMLSchema#string

P2860

Discrepancies in autologous bone marrow stem cell trials and enhancement of ejection fraction (DAMASCENE): weighted regression and meta-analysis

Stem cell treatment for acute myocardial infarction

Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis

Fibrinogen and fibrin based micro and nano scaffolds incorporated with drugs, proteins, cells and genes for therapeutic biomedical applications

Cell therapy for heart failure: a comprehensive overview of experimental and clinical studies, current challenges, and future directions

Magnetic targeting enhances retrograde cell retention in a rat model of myocardial infarction.

Magnetic targeting enhances engraftment and functional benefit of iron-labeled cardiosphere-derived cells in myocardial infarction.

Directed cardiomyogenesis of autologous human induced pluripotent stem cells recruited to infarcted myocardium with bioengineered antibodies.

Effect of intracoronary delivery of autologous bone marrow mononuclear cells 2 to 3 weeks following acute myocardial infarction on left ventricular function: the LateTIME randomized trial.

Magnetic antibody-linked nanomatchmakers for therapeutic cell targeting.

P304

2410-2413

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/JCMM.12912

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-07-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27469290

http://www.w3.org/2001/XMLSchema#string

P932

5134394

http://www.w3.org/2001/XMLSchema#string

Fibrin-targeting delivery: a novel platform for cardiac regenerative medicine.

about

P2860

P2860

Fibrin-targeting delivery: a novel platform for cardiac regenerative medicine.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932